EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of MR‐guided radiotherapy accumulated doses for central lung tumors with non‐adaptive and online adaptive proton therapy

Moritz Rabe iD, Miguel A Palacios, John R van Sörnsen de Koste, Chukwuka Eze iD, Martin Hillbrand, Claus Belka, Guillaume Landry, Suresh Senan iD, Christopher Kurz

Medical Physics · 2023

DOI: 10.1002/mp.16319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Physics, 2023. Verfasst von Moritz Rabe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Proton Therapy, Lung Neoplasms, Radiotherapy, Intensity-Modulated. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stereotactic body radiation therapy (SBRT) of central lung tumors with photon or proton therapy has a risk of increased toxicity. Treatment planning studies comparing accumulated doses for state‐of‐the‐art treatment techniques, such as MR‐guided radiotherapy (MRgRT) and intensity modulated proton therapy (IMPT), are currently lacking.

Purpose

We conducted a comparison of accumulated doses for MRgRT, robustly optimized non‐adaptive IMPT, and online adaptive IMPT for central lung tumors. A special focus was set on analyzing the accumulated doses to the bronchial tree, a parameter linked to high‐grade toxicities.

Methods

Data of 18 early‐stage central lung tumor patients, treated at a 0.35 T MR‐linac in eight or five fractions, were analyzed. Three gated treatment scenarios were compared: (S1) online adaptive MRgRT, (S2) non‐adaptive IMPT, and (S3) online adaptive IMPT. The treatment plans were recalculated or reoptimized on the daily imaging data acquired during MRgRT, and accumulated over all treatment fractions. Accumulated dose‐volume histogram (DVH) parameters of the gross tumor volume (GTV), lung, heart, and organs‐at‐risk (OARs) within 2 cm of the planning target volume (PTV) were extracted for each scenario and compared in Wilcoxon signed‐rank tests between S1 & S2, and S1 & S3.

Results

The accumulated GTV D 98% was above the prescribed dose for all patients and scenarios. Significant reductions ( p < 0.05) of the mean ipsilateral lung dose (S2: –8%; S3: –23%) and mean heart dose (S2: –79%; S3: –83%) were observed for both proton scenarios compared to S1. The bronchial tree D 0.1cc was significantly lower for S3 (S1: 48.1 Gy; S3: 39.2 Gy; p = 0.005), but not significantly different for S2 (S2: 45.0 Gy; p = 0.094), compared to S1. The D 0.1cc for S2 and S3 compared to S1 was significantly ( p < 0.05) smaller for OARs within 1–2 cm of the PTV (S1: 30.2 Gy; S2: 24.6 Gy; S3: 23.1 Gy), but not significantly different for OARs within 1 cm of the PTV.

Conclusions

A significant dose sparing potential of non‐adaptive and online adaptive proton therapy compared to MRgRT for OARs in close, but not direct proximity of central lung tumors was identified. The near‐maximum dose to the bronchial tree was not significantly different for MRgRT and non‐adaptive IMPT. Online adaptive IMPT achieved significantly lower doses to the bronchial tree compared to MRgRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyLung NeoplasmsRadiotherapy, Intensity-ModulatedHumansRadiotherapy Planning, Computer-AssistedLungRadiotherapy DosageOrgans at Risk

Stichwörter der Autor:innen

MR-linacbronchial treecentral lung tumordose accumulationonline adaptive proton therapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
  • Department of Radiation Oncology, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.
  • Institut für Radio-Onkologie, Kantonsspital Graubünden, Chur, Switzerland.
  • German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.

ORCID-Profile: Moritz Rabe, Chukwuka Eze, Suresh Senan

Zitieren

APA

Rabe, M., Palacios, M. A., van Sörnsen de Koste, J. R., Eze, C., Hillbrand, M., Belka, C., Landry, G., Senan, S., & Kurz, C. (2023). Comparison of MR‐guided radiotherapy accumulated doses for central lung tumors with non‐adaptive and online adaptive proton therapy. Medical Physics. https://doi.org/10.1002/mp.16319

Vancouver

Rabe M, Palacios MA, van Sörnsen de Koste JR, Eze C, Hillbrand M, Belka C, et al. Comparison of MR‐guided radiotherapy accumulated doses for central lung tumors with non‐adaptive and online adaptive proton therapy. Medical Physics. 2023. doi:10.1002/mp.16319

BibTeX
@article{Rabe2023,
  author = {Rabe, Moritz and Palacios, Miguel A and van Sörnsen de Koste, John R and Eze, Chukwuka and Hillbrand, Martin and Belka, Claus and Landry, Guillaume and Senan, Suresh and Kurz, Christopher},
  title = {Comparison of MR‐guided radiotherapy accumulated doses for central lung tumors with non‐adaptive and online adaptive proton therapy},
  journal = {Medical Physics},
  year = {2023},
  doi = {10.1002/mp.16319}
}
Kostenlos starten →